Abstract 869
Background
While the combined modality treatment of concurrent chemoradiotherapy (CCRT) with or without adjuvant chemotherapy has now been accepted as the standard treatment for advanced Nasopharyngeal carcinoma (NPC), induction chemotherapy +concurrent chemoradiotherapy (ICRT) is commonly used as well. The prognosis of II NPC patients is favorable. We should be more mindful to living quality during/after treatment, length of hospital stay, treatment cost and so forth. Therefore, the purpose of this study is to contrast prognosis of stage II NPC patients underwent the following two treatment modalities: ICRT vs CCRT.
Methods
173 patients with American Joint Committee on Cancer 7th stage II NPC are included and divided into two groups: ICRT and CCRT. Induction chemotherapy consisted of 1 to 3 cycles of cisplatin plus fluorouracil or paclitaxel plus cisplatin. Concurrent chemotherapy includes cisplatin only. We retrospectively assess overall survival (OS), progression-free survival (PFS), locoregional free survival (LRFS) and distant metastasis free survival (DMFS).
Results
With a median follow up of 64.7 months, no significant differences are found in grade 3–4 hematologic toxicity, liver dysfunction and renal impairment between ICRT and CCRT groups. Univariable analyses show adding induction chemotherapy to CCRT significantly decreases 5-year OS (87.9% vs 95.5%, P = 0.033), PFS (74.0% vs 86.1%, P = 0 .035), LRFS (80.0% vs 91.2%, P = 0.016), but there is no statistically significant difference in DMFS (87.1% vs 94.7%, P = 0.095). In multivariable analyses, we find the consistent results that induction chemotherapy is a negative factor associated with OS (HR of death =3.768, 95% CI = 1.117 to 12.709; P = 0.032), PFS (HR of progression = 2.156, 95% CI = 1.060 to 4.386; P = 0.034), LRFS (HR of locoregional relapse = 2.435, 95% CI = 1.009 to 5.874; P = 0.048) and also DMFS (HR of metastasis = 2.873, 95% CI = 1.005 to 8.211; P = 0.049), in stage II NPC patients.
Conclusions
In present study, we find that induction chemotherapy causes deleterious effect on stage II NPC patients. However, this is a retrospective study and the adverse effects of induction chemotherapy has not been previously reported. It warrants further investigation.
Clinical trial identification
Legal entity responsible for the study
Zhejiang Cancer Hospital.
Funding
Has not received any funding.
Editorial Acknowledgement
The authors indicated no potential conflicts of interest.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1159 - Molecular characterization and search for founding effects in Canarian families with Hereditary Breast and Ovarian Cancer Syndrome
Presenter: Elisenda Llabres Valenti
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3725 - Effect of the polymorphism rs2066844 of the NOD2 gene on colon cancer incidence in a high cardiovascular risk population. Modulation by gender
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3708 - Effect of the polymorphisms rs1476413, rs1801131, rs4846052 and rs6541003 of the MTHFR gene on prostate cancer in a high cardiovascular risk population
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5057 - Association of a genetic variant in cyclin-dependent kinase Inhibitor 2A gene with the increased risk of breast cancer
Presenter: Soodabeh Shahid Sales
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5970 - Investigating the role of HAT protein TIP60 in regulating functional dynamics of nuclear receptor PXR
Presenter: KARISHMA BAKSHI
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1360 - The role of downregulated SIRT3 expression in patients with hepatocellular carcinoma
Presenter: Hanhee Jo
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1634 - Prediction and Intervention of Colorectal Cancer Risk with Artificial Intelligent System
Presenter: Yang Ge
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
4921 - Measuring the Efficiency of Cancer Care in Europe
Presenter: Rikard Althin
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1235 - Circulating cell-free DNA isolated from plasma of mesenteric veins predicts prognosis in stage II colorectal cancer patients
Presenter: Chih-Yung Yang
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5169 - _lonality of uterine carcinosarcoma as a factor of clinical prognosis.
Presenter: Natalia Levitskaya
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract